| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5P3 GPR173 OR2W1 OR5K3 OPN1SW F2RL2 GRPR OR6M1 OR8G1 OR9A1P OR10G6 TAS2R3 TAS2R1 ACKR3 AGTR2 HRH4 OR4B1 OR51G1 GPR132 OR51B2 HCRTR1 HRH3 | 6.84e-07 | 884 | 149 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 OR5P3 ITGA11 GPR173 OR2W1 OR5K3 PTPRU OPN1SW F2RL2 GRPR OR6M1 OR8G1 OR9A1P OR10G6 TAS2R3 TAS2R1 ACKR3 AGTR2 HRH4 OR4B1 OR51G1 IL1R1 IL1RAP GPR132 OR51B2 HCRTR1 HRH3 | 2.41e-06 | 1353 | 149 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 4.03e-06 | 5 | 149 | 3 | GO:0141003 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 5.53e-05 | 2 | 149 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | aspartate:glutamate, proton antiporter activity | 5.53e-05 | 2 | 149 | 2 | GO:0000515 | |
| GeneOntologyMolecularFunction | 3-sulfino-L-alanine: proton, glutamate antiporter activity | 5.53e-05 | 2 | 149 | 2 | GO:0000514 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 5.53e-05 | 2 | 149 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 9.94e-05 | 62 | 149 | 5 | GO:0016627 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.16e-04 | 34 | 149 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.65e-04 | 3 | 149 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.65e-04 | 3 | 149 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.00e-04 | 39 | 149 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | guanine transmembrane transporter activity | 3.29e-04 | 4 | 149 | 2 | GO:0015208 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 4.23e-04 | 20 | 149 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 5.45e-04 | 5 | 149 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | glycolipid mannosyltransferase activity | 5.45e-04 | 5 | 149 | 2 | GO:0004376 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation antiporter activity | 5.45e-04 | 5 | 149 | 2 | GO:0140848 | |
| GeneOntologyMolecularFunction | histamine receptor activity | 8.13e-04 | 6 | 149 | 2 | GO:0004969 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.05e-03 | 211 | 149 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | G protein-coupled acetylcholine receptor activity | 1.13e-03 | 7 | 149 | 2 | GO:0016907 | |
| GeneOntologyMolecularFunction | histone kinase activity | 1.16e-03 | 28 | 149 | 3 | GO:0035173 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.47e-03 | 288 | 149 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | interleukin-1 receptor activity | 1.50e-03 | 8 | 149 | 2 | GO:0004908 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5P3 OR2W1 OR5K3 OR6M1 OR8G1 OR9A1P OR10G6 OR4B1 OR51G1 OR51B2 | 1.50e-03 | 431 | 149 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.89e-03 | 33 | 149 | 3 | GO:0033764 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 4.69e-06 | 16 | 151 | 4 | GO:1900034 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5P3 GPR173 OR2W1 OR5K3 OPN1SW F2RL2 GRPR OR6M1 OR8G1 OR9A1P OR10G6 TAS2R3 TAS2R1 PIK3CB ACKR3 AGTR2 AKR1C3 HRH4 OR4B1 OR51G1 NOS2 GPR132 OR51B2 HCRTR1 HRH3 | 2.75e-05 | 1395 | 151 | 25 | GO:0007186 |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 5.32e-05 | 2 | 151 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 5.32e-05 | 2 | 151 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 5.32e-05 | 2 | 151 | 2 | GO:1904882 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | NPC1 PTGES2 UGT1A7 UGT1A5 NAIP SHMT1 GPAM CPT1B SLC25A12 SLC25A13 AKR1C3 ELOVL3 DECR2 ACMSD GPT2 NOS2 EP300 FOXK1 SDHB WDTC1 | 6.90e-05 | 1035 | 151 | 20 | GO:0019752 |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | PIGB IP6K3 AGPAT4 SHMT1 GPAM CEPT1 SLC25A12 GUCY1B1 PIK3CB SLC25A13 ELOVL3 ATM ACMSD NOS2 SDHB | 7.94e-05 | 644 | 151 | 15 | GO:0090407 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | NPC1 PTGES2 UGT1A7 UGT1A5 NAIP SHMT1 GPAM CPT1B SLC25A12 SLC25A13 AKR1C3 ELOVL3 DECR2 ACMSD GPT2 NOS2 EP300 FOXK1 SDHB WDTC1 | 9.32e-05 | 1058 | 151 | 20 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | NPC1 PTGES2 UGT1A7 UGT1A5 NAIP SHMT1 GPAM CPT1B SLC25A12 SLC25A13 AKR1C3 ELOVL3 DECR2 ACMSD GPT2 NOS2 EP300 FOXK1 SDHB WDTC1 | 1.01e-04 | 1064 | 151 | 20 | GO:0006082 |
| GeneOntologyBiologicalProcess | tRNA export from nucleus | 1.59e-04 | 3 | 151 | 2 | GO:0006409 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization to telomere | 1.59e-04 | 3 | 151 | 2 | GO:0097694 | |
| GeneOntologyBiologicalProcess | establishment of protein-containing complex localization to telomere | 1.59e-04 | 3 | 151 | 2 | GO:0097695 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5P3 OR2W1 OR5K3 OR6M1 OR8G1 OR9A1P OR10G6 TAS2R3 TAS2R1 OR4B1 OR51G1 CFAP69 OR51B2 | 1.99e-04 | 547 | 151 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5P3 OR2W1 OR5K3 OR6M1 OR8G1 OR9A1P OR10G6 TAS2R3 TAS2R1 OR4B1 OR51G1 OR51B2 | 2.44e-04 | 485 | 151 | 12 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5P3 PIEZO1 NAIP OR2W1 OR5K3 OPN1SW OR6M1 OR8G1 OR9A1P OR10G6 TAS2R3 TAS2R1 OR4B1 OR51G1 OR51B2 | 2.76e-04 | 722 | 151 | 15 | GO:0051606 |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | RDH8 PTGES2 PIGB IP6K3 AGPAT4 GPAM CEPT1 ST3GAL6 PIK3CB DHCR7 AKR1C3 ELOVL3 DECR2 ATM HSD17B11 WDTC1 | 3.14e-04 | 813 | 151 | 16 | GO:0008610 |
| GeneOntologyBiologicalProcess | guanine transmembrane transport | 3.16e-04 | 4 | 151 | 2 | GO:1903716 | |
| GeneOntologyBiologicalProcess | hypoxanthine transport | 3.16e-04 | 4 | 151 | 2 | GO:0035344 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 3.16e-04 | 4 | 151 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | guanine transport | 3.16e-04 | 4 | 151 | 2 | GO:0015854 | |
| HumanPheno | Abnormal forearm bone morphology | 4.23e-05 | 236 | 38 | 9 | HP:0040072 | |
| HumanPheno | Frontal hirsutism | 4.43e-05 | 10 | 38 | 3 | HP:0011335 | |
| HumanPheno | Pes planus | ATR BAZ1B CREBBP ALG2 SIL1 FANCD2 SLC9A7 EP300 SLX4 VPS13B CHST3 | 4.53e-05 | 365 | 38 | 11 | HP:0001763 |
| HumanPheno | Abnormal forearm morphology | 4.68e-05 | 239 | 38 | 9 | HP:0002973 | |
| HumanPheno | Plantar crease between first and second toes | 5.42e-05 | 2 | 38 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 5.42e-05 | 2 | 38 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 5.42e-05 | 2 | 38 | 2 | HP:0001042 | |
| HumanPheno | Aplasia/hypoplasia involving forearm bones | 8.17e-05 | 100 | 38 | 6 | HP:0006503 | |
| HumanPheno | Abnormal uterus morphology | 1.36e-04 | 158 | 38 | 7 | HP:0031105 | |
| HumanPheno | Nasogastric tube feeding in infancy | 1.46e-04 | 37 | 38 | 4 | HP:0011470 | |
| HumanPheno | Abnormal morphology of the radius | 1.54e-04 | 217 | 38 | 8 | HP:0002818 | |
| HumanPheno | Laryngeal cartilage malformation | 1.62e-04 | 3 | 38 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.62e-04 | 3 | 38 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.62e-04 | 3 | 38 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.62e-04 | 3 | 38 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.62e-04 | 3 | 38 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.62e-04 | 3 | 38 | 2 | HP:0005895 | |
| HumanPheno | Preaxial polydactyly | 1.71e-04 | 164 | 38 | 7 | HP:0100258 | |
| HumanPheno | Cellular immunodeficiency | 1.80e-04 | 39 | 38 | 4 | HP:0005374 | |
| HumanPheno | Abnormal 5th finger morphology | ATR DYNC2H1 BAZ1B CREBBP FANCD2 DHCR7 SLC9A7 EP300 SLX4 TCTN1 VPS13B CHST3 | 2.07e-04 | 509 | 38 | 12 | HP:0004207 |
| HumanPheno | Forearm undergrowth | 2.08e-04 | 75 | 38 | 5 | HP:0009821 | |
| HumanPheno | Abnormal morphology of bones of the upper limbs | ATR DYNC2H1 BAZ1B CREBBP SIL1 FANCD2 DHCR7 EP300 SLX4 VPS13B CHST3 | 2.28e-04 | 436 | 38 | 11 | HP:0040065 |
| HumanPheno | Mitral valve prolapse | 2.57e-04 | 123 | 38 | 6 | HP:0001634 | |
| HumanPheno | Facial hirsutism | 2.89e-04 | 18 | 38 | 3 | HP:0009937 | |
| HumanPheno | Trichiasis | 3.22e-04 | 4 | 38 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 3.22e-04 | 4 | 38 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 3.22e-04 | 4 | 38 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 3.22e-04 | 4 | 38 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 3.22e-04 | 4 | 38 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 3.22e-04 | 4 | 38 | 2 | HP:0031207 | |
| HumanPheno | Abnormal conjugate eye movement | NPC1 ATR BAZ1B PGM2L1 CREBBP ALG2 HPS3 SIL1 FANCD2 ACKR3 DHCR7 SLC9A7 ATM EP300 SLX4 TCTN1 VPS13B UNC80 CHST3 | 3.26e-04 | 1198 | 38 | 19 | HP:0000549 |
| HumanPheno | Blepharophimosis | 3.33e-04 | 129 | 38 | 6 | HP:0000581 | |
| HumanPheno | Abnormal dermatoglyphics | 3.80e-04 | 314 | 38 | 9 | HP:0007477 | |
| HumanPheno | Upper limb undergrowth | 3.95e-04 | 86 | 38 | 5 | HP:0009824 | |
| HumanPheno | Absent earlobe | 4.00e-04 | 20 | 38 | 3 | HP:0000387 | |
| HumanPheno | Lower extremity joint dislocation | 4.17e-04 | 318 | 38 | 9 | HP:0030311 | |
| HumanPheno | Abnormal earlobe morphology | 4.61e-04 | 137 | 38 | 6 | HP:0000363 | |
| HumanPheno | Cafe-au-lait spot | 4.61e-04 | 137 | 38 | 6 | HP:0000957 | |
| HumanPheno | Localized hirsutism | 4.64e-04 | 21 | 38 | 3 | HP:0009889 | |
| HumanPheno | Slanting of the palpebral fissure | PIGB ATR PGM2L1 CREBBP ALG2 CYFIP2 FANCD2 DHCR7 SLC9A7 EP300 SLX4 VPS13B UNC80 CHST3 | 5.28e-04 | 739 | 38 | 14 | HP:0200006 |
| HumanPheno | Papillary cystadenoma of the epididymis | 5.34e-04 | 5 | 38 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 5.34e-04 | 5 | 38 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 5.34e-04 | 5 | 38 | 2 | HP:0030421 | |
| HumanPheno | Abnormal upper limb bone morphology | ATR DYNC2H1 BAZ1B CREBBP SIL1 FANCD2 DHCR7 EP300 SLX4 VPS13B CHST3 | 5.67e-04 | 484 | 38 | 11 | HP:0040070 |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 5.93e-04 | 53 | 38 | 4 | HP:0009906 | |
| HumanPheno | Abnormal thumb morphology | PIGB DYNC2H1 BAZ1B CREBBP FANCD2 DHCR7 EP300 SLX4 TCTN1 CHST3 | 5.96e-04 | 408 | 38 | 10 | HP:0001172 |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | PIGB ATR DYNC2H1 CREBBP SIL1 FANCD2 DHCR7 EP300 SLX4 VPS13B UNC80 CHST3 | 6.16e-04 | 572 | 38 | 12 | HP:0006496 |
| HumanPheno | Dislocated radial head | 6.38e-04 | 54 | 38 | 4 | HP:0003083 | |
| HumanPheno | Abnormal mitral valve morphology | 6.47e-04 | 146 | 38 | 6 | HP:0031477 | |
| HumanPheno | Sandal gap | 6.57e-04 | 96 | 38 | 5 | HP:0001852 | |
| HumanPheno | Hypoplasia of the ulna | 6.84e-04 | 55 | 38 | 4 | HP:0003022 | |
| HumanPheno | Strabismus | ATR BAZ1B PGM2L1 CREBBP ALG2 HPS3 SIL1 FANCD2 ACKR3 DHCR7 SLC9A7 ATM EP300 SLX4 TCTN1 VPS13B UNC80 CHST3 | 6.97e-04 | 1159 | 38 | 18 | HP:0000486 |
| HumanPheno | Downslanted palpebral fissures | ATR PGM2L1 CREBBP ALG2 CYFIP2 DHCR7 SLC9A7 EP300 VPS13B UNC80 CHST3 | 7.11e-04 | 497 | 38 | 11 | HP:0000494 |
| HumanPheno | Abnormal morphology of bones of the lower limbs | ATR DYNC2H1 CREBBP PLEKHM1 SIL1 FANCD2 EP300 SLX4 VPS13B CHST3 | 7.78e-04 | 422 | 38 | 10 | HP:0040066 |
| HumanPheno | Abnormality of the radial head | 7.84e-04 | 57 | 38 | 4 | HP:0003995 | |
| HumanPheno | Prominent antitragus | 7.98e-04 | 6 | 38 | 2 | HP:0008593 | |
| HumanPheno | Large foramen magnum | 7.98e-04 | 6 | 38 | 2 | HP:0002700 | |
| HumanPheno | Short long bone | 8.29e-04 | 278 | 38 | 8 | HP:0003026 | |
| HumanPheno | Phonophobia | 8.85e-04 | 26 | 38 | 3 | HP:0002183 | |
| HumanPheno | Aplasia/Hypoplasia of the ulna | 9.52e-04 | 60 | 38 | 4 | HP:0006495 | |
| HumanPheno | Abnormality of the palpebral fissures | PIGB ATR BAZ1B PGM2L1 CREBBP ALG2 CYFIP2 FANCD2 DHCR7 SLC9A7 EP300 SLX4 VPS13B UNC80 CHST3 | 9.65e-04 | 880 | 38 | 15 | HP:0008050 |
| HumanPheno | Broad distal phalanx of finger | 9.90e-04 | 27 | 38 | 3 | HP:0009836 | |
| HumanPheno | Abnormal incisor morphology | 1.08e-03 | 62 | 38 | 4 | HP:0011063 | |
| HumanPheno | Abnormality of the humeroradial joint | 1.08e-03 | 62 | 38 | 4 | HP:0100744 | |
| HumanPheno | Deviated nasal septum | 1.11e-03 | 7 | 38 | 2 | HP:0004411 | |
| HumanPheno | Epicanthus | DYNC2H1 PIEZO1 BAZ1B PGM2L1 CREBBP ALG2 FANCD2 DHCR7 GPT2 EP300 SLX4 UNC80 | 1.17e-03 | 614 | 38 | 12 | HP:0000286 |
| HumanPheno | Multiple cafe-au-lait spots | 1.21e-03 | 64 | 38 | 4 | HP:0007565 | |
| HumanPheno | Prominent nose | 1.22e-03 | 110 | 38 | 5 | HP:0000448 | |
| Domain | GPCR_Rhodpsn | OR5P3 GPR173 OR2W1 OR5K3 OR3A4P OPN1SW F2RL2 GRPR OR6M1 OR8G1 OR10G6 TAS2R3 ACKR3 AGTR2 HRH4 OR4B1 OR51G1 GPR132 OR51B2 HCRTR1 HRH3 | 1.64e-07 | 692 | 150 | 21 | IPR000276 |
| Domain | 7tm_1 | OR5P3 GPR173 OR2W1 OR5K3 OR3A4P OPN1SW F2RL2 GRPR OR6M1 OR8G1 OR10G6 ACKR3 AGTR2 HRH4 OR4B1 OR51G1 GPR132 OR51B2 HCRTR1 HRH3 | 5.08e-07 | 677 | 150 | 20 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5P3 GPR173 OR2W1 OR5K3 OR3A4P OPN1SW F2RL2 GRPR OR6M1 OR8G1 OR10G6 ACKR3 AGTR2 HRH4 OR4B1 OR51G1 GPR132 OR51B2 HCRTR1 HRH3 | 6.11e-07 | 685 | 150 | 20 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5P3 GPR173 OR2W1 OR5K3 OR3A4P OPN1SW F2RL2 GRPR OR6M1 OR8G1 OR10G6 ACKR3 AGTR2 HRH4 OR4B1 OR51G1 GPR132 OR51B2 HCRTR1 HRH3 | 7.00e-07 | 691 | 150 | 20 | PS50262 |
| Domain | GPCR_Rhodpsn_7TM | OR5P3 GPR173 OR2W1 OR5K3 OPN1SW F2RL2 GRPR OR6M1 OR8G1 ACKR3 AGTR2 HRH4 OR4B1 OR51G1 GPR132 OR51B2 HCRTR1 HRH3 | 7.40e-06 | 670 | 150 | 18 | IPR017452 |
| Domain | Nuc_rcpt_coact_CREBbp | 6.41e-05 | 2 | 150 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 6.41e-05 | 2 | 150 | 2 | SM00551 | |
| Domain | - | 6.41e-05 | 2 | 150 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 6.41e-05 | 2 | 150 | 2 | IPR010303 | |
| Domain | - | 6.41e-05 | 2 | 150 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 6.41e-05 | 2 | 150 | 2 | PF09030 | |
| Domain | zf-TAZ | 6.41e-05 | 2 | 150 | 2 | PF02135 | |
| Domain | ZF_TAZ | 6.41e-05 | 2 | 150 | 2 | PS50134 | |
| Domain | KAT11 | 6.41e-05 | 2 | 150 | 2 | SM01250 | |
| Domain | Znf_TAZ | 6.41e-05 | 2 | 150 | 2 | IPR000197 | |
| Domain | KIX | 6.41e-05 | 2 | 150 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 6.41e-05 | 2 | 150 | 2 | PF08214 | |
| Domain | KIX | 6.41e-05 | 2 | 150 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 6.41e-05 | 2 | 150 | 2 | IPR031162 | |
| Domain | DUF902 | 6.41e-05 | 2 | 150 | 2 | PF06001 | |
| Domain | - | 6.41e-05 | 2 | 150 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 6.41e-05 | 2 | 150 | 2 | IPR013178 | |
| Domain | KIX_dom | 6.41e-05 | 2 | 150 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 6.41e-05 | 2 | 150 | 2 | PS51727 | |
| Domain | ARM-type_fold | USP34 ZYG11A ATR SIL1 PIK3CB ATM WDFY3 CFAP69 GCN1 TARBP1 XPOT | 9.46e-05 | 339 | 150 | 11 | IPR016024 |
| Domain | ZnF_TTF | 1.91e-04 | 3 | 150 | 2 | SM00597 | |
| Domain | Znf_TTF | 1.91e-04 | 3 | 150 | 2 | IPR006580 | |
| Domain | PI3/4_kinase_CS | 2.15e-04 | 15 | 150 | 3 | IPR018936 | |
| Domain | - | 2.63e-04 | 16 | 150 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.63e-04 | 16 | 150 | 3 | SM00146 | |
| Domain | PI3_PI4_kinase | 3.79e-04 | 18 | 150 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 3.79e-04 | 18 | 150 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.79e-04 | 18 | 150 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 3.79e-04 | 18 | 150 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 3.79e-04 | 18 | 150 | 3 | PS50290 | |
| Domain | FATC | 6.31e-04 | 5 | 150 | 2 | PF02260 | |
| Domain | ADH_SHORT | 8.62e-04 | 53 | 150 | 4 | PS00061 | |
| Domain | Nuc_rcpt_coact | 9.41e-04 | 6 | 150 | 2 | IPR009110 | |
| Domain | IL-1_rcpt_I/II-typ | 9.41e-04 | 6 | 150 | 2 | IPR004074 | |
| Domain | FAT | 9.41e-04 | 6 | 150 | 2 | PS51189 | |
| Domain | FATC | 9.41e-04 | 6 | 150 | 2 | PS51190 | |
| Domain | FAT | 9.41e-04 | 6 | 150 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 9.41e-04 | 6 | 150 | 2 | IPR003151 | |
| Domain | FATC_dom | 9.41e-04 | 6 | 150 | 2 | IPR003152 | |
| Domain | PIK_FAT | 9.41e-04 | 6 | 150 | 2 | IPR014009 | |
| Domain | FATC | 9.41e-04 | 6 | 150 | 2 | SM01343 | |
| Domain | adh_short | 9.92e-04 | 55 | 150 | 4 | PF00106 | |
| Domain | SDR_fam | 1.06e-03 | 56 | 150 | 4 | IPR002347 | |
| Domain | Bromodomain_CS | 1.15e-03 | 26 | 150 | 3 | IPR018359 | |
| Domain | Olfact_rcpt | OR5P3 OR2W1 OR5K3 OR3A4P OR6M1 OR8G1 OR10G6 OR4B1 OR51G1 OR51B2 | 1.31e-03 | 393 | 150 | 10 | IPR000725 |
| Domain | ARM-like | 1.55e-03 | 270 | 150 | 8 | IPR011989 | |
| Domain | HATC_C_dom | 1.74e-03 | 8 | 150 | 2 | IPR008906 | |
| Domain | Dimer_Tnp_hAT | 1.74e-03 | 8 | 150 | 2 | PF05699 | |
| Domain | - | 2.14e-03 | 222 | 150 | 7 | 1.25.10.10 | |
| Domain | BROMODOMAIN_1 | 3.23e-03 | 37 | 150 | 3 | PS00633 | |
| Domain | IL-1_rcpt_fam | 3.36e-03 | 11 | 150 | 2 | IPR015621 | |
| Domain | Bromodomain | 3.49e-03 | 38 | 150 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.33e-03 | 41 | 150 | 3 | PS50014 | |
| Domain | Bromodomain | 4.63e-03 | 42 | 150 | 3 | IPR001487 | |
| Domain | BROMO | 4.63e-03 | 42 | 150 | 3 | SM00297 | |
| Domain | - | 4.63e-03 | 42 | 150 | 3 | 1.20.920.10 | |
| Domain | Acyltransferase | 7.14e-03 | 16 | 150 | 2 | PF01553 | |
| Pubmed | p300/CREB-binding protein interacts with ATR and is required for the DNA replication checkpoint. | 8.51e-08 | 3 | 154 | 3 | 17272271 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 9858599 | ||
| Pubmed | Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. | 8.51e-08 | 3 | 154 | 3 | 16943440 | |
| Pubmed | FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. | 3.39e-07 | 4 | 154 | 3 | 18931676 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 16293623 | ||
| Pubmed | USP34 TUT7 NOL6 NUP98 BAZ1B DDX56 UTP18 FAM120A MYH14 SLC25A13 ATM GCN1 USP47 XPOT | 1.39e-06 | 653 | 154 | 14 | 22586326 | |
| Pubmed | NPC1 USP34 PTGES2 RAP1GAP VWF CREBBP FBXL16 FAM120A GUCY1B1 MYH14 AKR1C3 ATM WDFY3 CABIN1 TARBP1 EP300 SLX4 USP47 XPOT | 4.46e-06 | 1285 | 154 | 19 | 35914814 | |
| Pubmed | DNA damage repair machinery and HIV escape from innate immune sensing. | 4.69e-06 | 8 | 154 | 3 | 24795708 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 4.91e-06 | 211 | 154 | 8 | 17314511 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATR DYNC2H1 MRPL37 NOL6 NUP98 BAZ1B DDX56 CYFIP2 FANCD2 UTP18 FAM120A MYH14 DHCR7 SLC25A13 ATM GCN1 IQGAP3 SDHB XPOT NPAS2 | 5.32e-06 | 1425 | 154 | 20 | 30948266 |
| Pubmed | DYNC2H1 MRPL37 NOL6 LRRC70 CREBBP EHBP1L1 MRPS24 SUPT7L WDFY3 TARBP1 EP300 CDH17 USP47 | 5.82e-06 | 638 | 154 | 13 | 31182584 | |
| Pubmed | HIV-1 chromatin, transcription, and the regulatory protein Tat. | 7.01e-06 | 9 | 154 | 3 | 24158816 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 USP34 PIEZO1 DDX56 SLC29A2 PLEKHM1 SIL1 EHBP1L1 MGAT1 SH3TC1 ADAMTS7 WDFY3 CABIN1 GCN1 IQGAP3 EP300 FOXK1 | 8.84e-06 | 1105 | 154 | 17 | 35748872 |
| Pubmed | 9.99e-06 | 10 | 154 | 3 | 17478428 | ||
| Pubmed | 9.99e-06 | 10 | 154 | 3 | 20347598 | ||
| Pubmed | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. | 1.14e-05 | 170 | 154 | 7 | 19064572 | |
| Pubmed | Activator-Mediator binding regulates Mediator-cofactor interactions. | 1.37e-05 | 11 | 154 | 3 | 20534441 | |
| Pubmed | 1.37e-05 | 11 | 154 | 3 | 24800743 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 1.82e-05 | 12 | 154 | 3 | 14645221 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 27881875 | ||
| Pubmed | Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. | 1.95e-05 | 2 | 154 | 2 | 19285939 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 27624129 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25410934 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.95e-05 | 2 | 154 | 2 | 34845315 | |
| Pubmed | Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. | 1.95e-05 | 2 | 154 | 2 | 37338595 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19729597 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28851706 | ||
| Pubmed | Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM). | 1.95e-05 | 2 | 154 | 2 | 34151669 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 39287984 | ||
| Pubmed | Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome. | 1.95e-05 | 2 | 154 | 2 | 16213462 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20717166 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 27442013 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24726882 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25893291 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11559821 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26061708 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32576962 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19822209 | ||
| Pubmed | Voltage sensitivities and deactivation kinetics of histamine H₃ and H₄ receptors. | 1.95e-05 | 2 | 154 | 2 | 22885137 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24522976 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 1.95e-05 | 2 | 154 | 2 | 21847097 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20103595 | ||
| Pubmed | Sodium binding to hH3R and hH 4R--a molecular modeling study. | 1.95e-05 | 2 | 154 | 2 | 25098339 | |
| Pubmed | Interplay between ATM and ATR in the regulation of common fragile site stability. | 1.95e-05 | 2 | 154 | 2 | 17934520 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25483091 | ||
| Pubmed | ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. | 1.95e-05 | 2 | 154 | 2 | 23592994 | |
| Pubmed | Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. | 1.95e-05 | 2 | 154 | 2 | 7775431 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 1.95e-05 | 2 | 154 | 2 | 34813504 | |
| Pubmed | Propolypeptide of von Willebrand factor is a novel ligand for very late antigen-4 integrin. | 1.95e-05 | 2 | 154 | 2 | 9079671 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19527713 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20301699 | ||
| Pubmed | ATM-ROS-iNOS axis regulates nitric oxide mediated cellular senescence. | 1.95e-05 | 2 | 154 | 2 | 27845209 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24639469 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 1.95e-05 | 2 | 154 | 2 | 11438528 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10918613 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26567218 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 35502657 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 31898871 | ||
| Pubmed | Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. | 1.95e-05 | 2 | 154 | 2 | 9211850 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 1.95e-05 | 2 | 154 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 1.95e-05 | 2 | 154 | 2 | 27881443 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19272189 | ||
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 1.95e-05 | 2 | 154 | 2 | 32690000 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 30953353 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21803292 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 33742106 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 9811832 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24089570 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17213189 | ||
| Pubmed | Roles of ATM and ATR in DNA double strand breaks and replication stress. | 1.95e-05 | 2 | 154 | 2 | 33887296 | |
| Pubmed | Evolutionarily conserved human targets of adenosine to inosine RNA editing. | 1.95e-05 | 2 | 154 | 2 | 15731336 | |
| Pubmed | ATR disruption leads to chromosomal fragmentation and early embryonic lethality. | 1.95e-05 | 2 | 154 | 2 | 10691732 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 1.95e-05 | 2 | 154 | 2 | 39266679 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 22303793 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 31114877 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 35011623 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 34732714 | ||
| Pubmed | IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. | 1.95e-05 | 2 | 154 | 2 | 14693705 | |
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 1.95e-05 | 2 | 154 | 2 | 34019788 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26517239 | ||
| Pubmed | Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors. | 1.95e-05 | 2 | 154 | 2 | 18345506 | |
| Pubmed | DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress. | 1.95e-05 | 2 | 154 | 2 | 21593482 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25232030 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15860545 | ||
| Pubmed | ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. | 1.95e-05 | 2 | 154 | 2 | 18757420 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 29460469 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 22118942 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11927575 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28820634 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 29279380 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 12526805 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 1.95e-05 | 2 | 154 | 2 | 24551300 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 33911074 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 9018065 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24648406 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 30135524 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 1.95e-05 | 2 | 154 | 2 | 16596650 | |
| Pubmed | The transcription factor FoxK participates with Nup98 to regulate antiviral gene expression. | 1.95e-05 | 2 | 154 | 2 | 25852164 | |
| GeneFamily | Histamine receptors | 1.95e-04 | 4 | 104 | 2 | 187 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 9.65e-04 | 76 | 104 | 4 | 743 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CASS4 IP6K3 AGPAT4 ITGA4 CREBBP CYFIP2 GVINP1 ADAMDEC1 IQGAP3 | 5.51e-09 | 162 | 154 | 9 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 158 | 154 | 7 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.39e-06 | 159 | 154 | 7 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.61e-06 | 135 | 154 | 6 | 641d42a005ff61f21e6cda02bfbd0bd1d4ba2faa | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 84 | 154 | 5 | 6c8018d65df335c81fe4099a34e0053c8dbcf88d | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-05 | 154 | 154 | 6 | 1c62290a2558fd6401b27de5a867d243b143b00a | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 156 | 154 | 6 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 156 | 154 | 6 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 173 | 154 | 6 | b367b62309389e8b6a65de83c2434dc8ec905985 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 177 | 154 | 6 | 76f5df101c693e5fa61554244d877fc8169ee66f | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.65e-05 | 178 | 154 | 6 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 108 | 154 | 5 | ee924deacd14ea404fda80ed633960143fd474c0 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-05 | 182 | 154 | 6 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 182 | 154 | 6 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.13e-05 | 182 | 154 | 6 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 183 | 154 | 6 | ab38264daddccdf5ffb75ff2210b27423eca6bc0 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 183 | 154 | 6 | e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 183 | 154 | 6 | 263bfa1d8a7314bc3156c735c403c3bab8ea4dac | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.39e-05 | 184 | 154 | 6 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 185 | 154 | 6 | a3b937163346d729115e6335336e33d3e71fccb0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 188 | 154 | 6 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 188 | 154 | 6 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.24e-05 | 190 | 154 | 6 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 191 | 154 | 6 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 191 | 154 | 6 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.88e-05 | 194 | 154 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.40e-05 | 197 | 154 | 6 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| Drug | NF-058 | 1.63e-05 | 8 | 153 | 3 | CID000369605 | |
| Drug | cyclopropyl ketone | 1.63e-05 | 8 | 153 | 3 | CID000070721 | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.85e-05 | 186 | 153 | 8 | 5777_DN | |
| Drug | impentamine | 4.49e-05 | 2 | 153 | 2 | CID009793868 | |
| Drug | curlone | 4.49e-05 | 2 | 153 | 2 | CID000196216 | |
| Drug | bonanzin | 4.49e-05 | 2 | 153 | 2 | CID005379563 | |
| Drug | homohistamine | 4.49e-05 | 2 | 153 | 2 | CID000170389 | |
| Drug | aplysamine | 4.49e-05 | 2 | 153 | 2 | CID000362025 | |
| Drug | connessine | 4.49e-05 | 2 | 153 | 2 | CID000002860 | |
| Drug | VUF 8328 | 4.49e-05 | 2 | 153 | 2 | CID010176414 | |
| Drug | SC-359 | 4.49e-05 | 2 | 153 | 2 | CID000022970 | |
| Drug | iodophenpropit | 4.49e-05 | 2 | 153 | 2 | CID003035746 | |
| Drug | immethridine | 4.49e-05 | 2 | 153 | 2 | CID009989505 | |
| Drug | Cipralisant [inn] | 4.49e-05 | 2 | 153 | 2 | CID006433105 | |
| Drug | phenoxytoluene | 4.49e-05 | 2 | 153 | 2 | CID000070352 | |
| Drug | imbutamine | 4.49e-05 | 2 | 153 | 2 | CID013499360 | |
| Drug | proxyfan | 4.49e-05 | 2 | 153 | 2 | CID006421522 | |
| Drug | JNJ7777120 | 4.49e-05 | 2 | 153 | 2 | CID004908365 | |
| Drug | santin | 4.49e-05 | 2 | 153 | 2 | CID005281695 | |
| Drug | burimamide | 4.49e-05 | 2 | 153 | 2 | CID003032915 | |
| Drug | piperidine-1-carbothioamide | 4.49e-05 | 2 | 153 | 2 | CID001551232 | |
| Drug | methimepip | 4.49e-05 | 2 | 153 | 2 | CID011313836 | |
| Drug | AC1O46V6 | 4.49e-05 | 2 | 153 | 2 | CID006400683 | |
| Drug | semustine; Up 200; 100uM; PC3; HT_HG-U133A | 5.19e-05 | 194 | 153 | 8 | 7492_UP | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.19e-05 | 194 | 153 | 8 | 2621_UP | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.38e-05 | 195 | 153 | 8 | 6310_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 5.78e-05 | 197 | 153 | 8 | 2259_DN | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A | 5.99e-05 | 198 | 153 | 8 | 2799_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.99e-05 | 198 | 153 | 8 | 2251_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 6.43e-05 | 200 | 153 | 8 | 6839_UP | |
| Drug | mangrove | NPC1 GPAM CPT1B FANCD2 MGAT1 SLC25A12 GUCY1B1 PIK3CB SLC25A13 DECR2 ACMSD NOS2 | 7.98e-05 | 468 | 153 | 12 | CID000000965 |
| Drug | pterin | 9.09e-05 | 108 | 153 | 6 | CID000073000 | |
| Drug | tsuwabukinonol | 1.09e-04 | 37 | 153 | 4 | CID006440419 | |
| Drug | 1,5-diphenyl-3-dimethylaminopyrrolidine | 1.34e-04 | 3 | 153 | 2 | CID003016476 | |
| Drug | imetit | 1.34e-04 | 3 | 153 | 2 | ctd:C077430 | |
| Drug | Da-4626 | 1.34e-04 | 3 | 153 | 2 | CID000134179 | |
| Drug | DA 4360 | 1.34e-04 | 3 | 153 | 2 | CID000134176 | |
| Drug | Lupitidinum | 1.34e-04 | 3 | 153 | 2 | CID000051670 | |
| Drug | AHR-9294 | 1.34e-04 | 3 | 153 | 2 | CID000134395 | |
| Drug | AC1L18BD | 1.34e-04 | 3 | 153 | 2 | CID000000028 | |
| Drug | AC1L61GL | 1.34e-04 | 3 | 153 | 2 | CID000284703 | |
| Drug | 2,3,4,5-tetrahydro-1,5-benzothiazepine | 1.34e-04 | 3 | 153 | 2 | CID000093962 | |
| Drug | bilastine | 1.34e-04 | 3 | 153 | 2 | CID000185460 | |
| Drug | 3-amino-4-methylfurazan | 1.34e-04 | 3 | 153 | 2 | CID000028674 | |
| Drug | plocamadiene A | 1.34e-04 | 3 | 153 | 2 | CID006441110 | |
| Drug | 6-azidoketanserin | 1.34e-04 | 3 | 153 | 2 | CID003035767 | |
| Drug | thiaburimamide | 1.34e-04 | 3 | 153 | 2 | CID003034473 | |
| Drug | 2-naphthalenesulfonyl chloride | 1.34e-04 | 3 | 153 | 2 | CID000007125 | |
| Drug | sapindoside C | 1.34e-04 | 3 | 153 | 2 | CID006325966 | |
| Drug | N'(Me),5(Me)histamine | 1.34e-04 | 3 | 153 | 2 | CID000104662 | |
| Drug | diethyl 2-chloroazulene-1,3-dicarboxylate | 1.34e-04 | 3 | 153 | 2 | CID010244674 | |
| Drug | N-methylhistamine | 1.34e-04 | 3 | 153 | 2 | ctd:C048140 | |
| Drug | SU416 | 1.34e-04 | 3 | 153 | 2 | CID000012656 | |
| Drug | SKF 91486 | 1.34e-04 | 3 | 153 | 2 | CID000182527 | |
| Drug | phenoxymethyl | 1.34e-04 | 3 | 153 | 2 | CID000134735 | |
| Drug | E-2-P | 1.34e-04 | 3 | 153 | 2 | CID000132894 | |
| Drug | Salicylic Acid | 1.34e-04 | 39 | 153 | 4 | ctd:D020156 | |
| Drug | pyruvic acid | VWF SGCG SHMT1 PGM2L1 CPT1B PLEKHM1 FANCD2 SLC25A12 GPT2 NOS2 SDHB | 1.44e-04 | 424 | 153 | 11 | CID000001060 |
| Drug | thymoquinone | 1.48e-04 | 40 | 153 | 4 | CID000010281 | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 2.30e-05 | 2 | 142 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.30e-05 | 2 | 142 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.30e-05 | 2 | 142 | 2 | cv:C4551859 | |
| Disease | common bile duct disease (implicated_via_orthology) | 2.30e-05 | 2 | 142 | 2 | DOID:4137 (implicated_via_orthology) | |
| Disease | Menke-Hennekam syndrome | 2.30e-05 | 2 | 142 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.30e-05 | 2 | 142 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.30e-05 | 2 | 142 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.30e-05 | 2 | 142 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.30e-05 | 2 | 142 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.30e-05 | 2 | 142 | 2 | C0035934 | |
| Disease | citrullinemia (implicated_via_orthology) | 6.88e-05 | 3 | 142 | 2 | DOID:9273 (implicated_via_orthology) | |
| Disease | intrahepatic cholestasis (implicated_via_orthology) | 1.37e-04 | 4 | 142 | 2 | DOID:1852 (implicated_via_orthology) | |
| Disease | pancreatic cancer (is_implicated_in) | 2.13e-04 | 112 | 142 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | vitamin D measurement | 2.33e-04 | 336 | 142 | 8 | EFO_0004631 | |
| Disease | lumbar disc degeneration | 3.27e-04 | 28 | 142 | 3 | EFO_0004994 | |
| Disease | anxiety, smoking behaviour measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0005230, EFO_0005671 | |
| Disease | Disorders of Sex Development | 4.75e-04 | 7 | 142 | 2 | C0036875 | |
| Disease | X-11793--oxidized bilirubin measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0021249 | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 6.32e-04 | 8 | 142 | 2 | DOID:1312 (is_marker_for) | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0802740 | |
| Disease | X-16946 measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0800766 | |
| Disease | X-11442 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 8.10e-04 | 9 | 142 | 2 | EFO_0004570, GO_0009410 | |
| Disease | fibrinogen measurement, coronary artery disease | 9.16e-04 | 154 | 142 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | bilirubin measurement, response to tenofovir | 1.01e-03 | 10 | 142 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0800867 | |
| Disease | abdominal aortic calcification measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0010272 | |
| Disease | interleukin 1 receptor-like 1 measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0008168 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 1.23e-03 | 11 | 142 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | pregnenetriol sulfate measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 1.47e-03 | 12 | 142 | 2 | EFO_0800079 | |
| Disease | biliverdin measurement | 1.47e-03 | 12 | 142 | 2 | EFO_0021033 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.47e-03 | 12 | 142 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 1.53e-03 | 173 | 142 | 5 | C0023467 | |
| Disease | metabolite measurement | 1.61e-03 | 560 | 142 | 9 | EFO_0004725 | |
| Disease | pregnenetriol disulfate measurement | 1.73e-03 | 13 | 142 | 2 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 1.73e-03 | 13 | 142 | 2 | EFO_0802007 | |
| Disease | Fanconi anemia | 2.01e-03 | 14 | 142 | 2 | cv:C0015625 | |
| Disease | C-reactive protein measurement | NPC1 USP34 CWF19L2 RAP1GAP SGCG BAZ1B CYFIP2 LRRC55 SLC9A7 RMC1 IL1R1 GCN1 HCRTR1 USP47 | 2.09e-03 | 1206 | 142 | 14 | EFO_0004458 |
| Disease | factor VIII measurement, coronary artery disease | 2.21e-03 | 113 | 142 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Proteinuria | 2.32e-03 | 15 | 142 | 2 | HP_0000093 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.38e-03 | 55 | 142 | 3 | C0079744 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.44e-03 | 713 | 142 | 10 | EFO_0005689 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.58e-03 | 118 | 142 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 2.64e-03 | 16 | 142 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | phosphorus measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0004861 | |
| Disease | Benign neoplasm of stomach | 2.98e-03 | 17 | 142 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.98e-03 | 17 | 142 | 2 | C0496905 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.98e-03 | 17 | 142 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Carcinoma in situ of stomach | 2.98e-03 | 17 | 142 | 2 | C0154060 | |
| Disease | pre-eclampsia (biomarker_via_orthology) | 2.98e-03 | 17 | 142 | 2 | DOID:10591 (biomarker_via_orthology) | |
| Disease | X-21441 measurement | 2.98e-03 | 17 | 142 | 2 | EFO_0800814 | |
| Disease | angina pectoris | 3.18e-03 | 125 | 142 | 4 | EFO_0003913 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.27e-03 | 206 | 142 | 5 | C0152013 | |
| Disease | serum alanine aminotransferase measurement | NPC1 PTGES2 BTBD8 SGCG SHMT1 BAZ1B GPAM CYFIP2 ADAMTS7 RMC1 IL1R1 | 3.29e-03 | 869 | 142 | 11 | EFO_0004735 |
| Disease | angiopoietin-related protein 1 measurement | 3.35e-03 | 18 | 142 | 2 | EFO_0801382 | |
| Disease | Bone marrow hypocellularity | 3.35e-03 | 18 | 142 | 2 | C1855710 | |
| Disease | bipolar disorder (is_marker_for) | 3.73e-03 | 19 | 142 | 2 | DOID:3312 (is_marker_for) | |
| Disease | Stomach Carcinoma | 4.55e-03 | 21 | 142 | 2 | C0699791 | |
| Disease | tissue factor measurement | 4.55e-03 | 21 | 142 | 2 | EFO_0010623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFPFYNTVCILRKLF | 601 | Q13075 | |
| VYSPDCRFHSFKKVL | 306 | Q8TD30 | |
| SYLDSVHFFRPKCLR | 1396 | Q09472 | |
| RLSEHCRLYFGALFK | 671 | Q9NQ75 | |
| IFRLLKHAICAAEFY | 61 | Q96LI9 | |
| VECHPYFNRSKLLDF | 191 | P42330 | |
| AEYGHRCSPLFFLKS | 426 | Q8IUA7 | |
| NKAFHLFCLRPALYE | 1206 | Q9UIG0 | |
| KFSYIPLASCHFPID | 291 | Q7Z2Y8 | |
| FIATCYFGIRKHLLK | 226 | P50052 | |
| ISYLDSIHFFRPRCL | 1431 | Q92793 | |
| YAAAERLKCSLFVHP | 161 | Q8TDX5 | |
| YVHGCRLIFLFRQDP | 421 | O94985 | |
| HVSVPFLLAYCSSKF | 176 | Q8NBQ5 | |
| FQVLLYTSLPDFCHK | 106 | Q9UBM7 | |
| LHCRPANEYFAEKLR | 631 | Q9UKP4 | |
| LPNKATLGHFYERCI | 136 | Q8IWB1 | |
| FLPKYLSSPRCAALH | 456 | Q0D2K2 | |
| LEFYCHLLRGSLNPK | 166 | Q99743 | |
| YPRFCAFAHDIDQKL | 631 | P35228 | |
| FDLINHYFCDLLPLL | 171 | Q15617 | |
| TPLRDVCFHLLKLYS | 1486 | P52948 | |
| PALLYHKCQVVFFLL | 236 | Q86WK9 | |
| FKACHLTLTLDDYLF | 246 | Q6ZSA7 | |
| LKNPLGTFIFCHAYL | 291 | Q5VTA0 | |
| RLHRYDVFCFATALK | 251 | Q96S86 | |
| RDLFYKLAEAHPDCL | 156 | Q8IXH7 | |
| CLDKLLHYRPSAELF | 121 | P26572 | |
| KCPLFEHFLKFNYST | 46 | Q9NPH3 | |
| KSLLCHLPRIYQAFL | 181 | Q9NY93 | |
| CRDHSDPRQTFLYKL | 1391 | Q9P2D6 | |
| KADLLLEPCSHYRFL | 316 | Q7Z406 | |
| PVILRLFSFSYCKSH | 156 | Q9Y5P1 | |
| DRFTAICKPLHYFVV | 121 | Q9Y3N9 | |
| LPFLLKRFQYCHSHV | 161 | Q8NGK1 | |
| PYKACLSELFFFHLL | 96 | P47883 | |
| YPKFCGTFAILHVRD | 516 | Q6PCE3 | |
| LYCFDSSQFPKHLIV | 676 | Q2TBE0 | |
| HCLQEASPRYKSLRF | 461 | Q8N2G8 | |
| LHQVPYAVKGCFRFL | 141 | Q9H6R4 | |
| AYRHLFCPDLLRDKV | 16 | Q9NUI1 | |
| AFCAILHRFYPDKID | 1071 | Q8N3D4 | |
| GLFFFLPCLDTYHKV | 151 | Q9NP85 | |
| CAPLLRYLSHSEFKD | 246 | Q92616 | |
| YTFCKAFPFHIIFDR | 211 | Q02153 | |
| LCNIPYYFSAHALKL | 191 | Q9NZB2 | |
| PLRFHLKYEADVLFT | 946 | Q9UKX5 | |
| HFFCDVLPLYRLSCI | 176 | A6NET4 | |
| FDKLSPLHERIYCAL | 51 | P28065 | |
| RRFDLFDFCYHLLKV | 1196 | Q96F07 | |
| VTRLPYCRKEINHFF | 161 | Q8NGM8 | |
| FKPETFRKFLALYLH | 406 | Q9BZE1 | |
| LCSEYPENKRHRFLL | 186 | Q96PC2 | |
| PRVVYCIHALSLFLF | 136 | Q86VI3 | |
| PKAFVQLRHLYFLFL | 101 | Q7Z2Q7 | |
| FRDLYLPASRKLFCS | 216 | Q9NYR8 | |
| LLSYPCAKAPHFSRL | 181 | Q92729 | |
| LFCVTLPFKIAYHLN | 141 | O00254 | |
| CLFRFFKNSYSPLLL | 816 | O15118 | |
| DKCLQSPIYFFLGHL | 51 | Q8NGU1 | |
| YAICHPLLFKSTARR | 146 | O43613 | |
| AIRTIHEKFLYFLPA | 336 | Q8NCM8 | |
| DFYRSCYKVLIPHLV | 1246 | Q13315 | |
| LCHLLQYFLKFVPAG | 346 | Q13535 | |
| LFEKHPCLYILTFGF | 311 | Q9Y6K0 | |
| FYLLSFLLERKPCTI | 31 | P62952 | |
| FRLCLSRFPQHYKSL | 1516 | Q9Y6J0 | |
| AHFFCQTYIRPKVKA | 251 | Q9HB03 | |
| PSFACLKELYDLRQH | 156 | Q01850 | |
| AHKAVLLARVPDFYF | 71 | Q5XKL5 | |
| CVNPFALYLLSKSFR | 316 | P30550 | |
| LVPGALFHLYAACKS | 86 | A6NN92 | |
| LSFQEPHFYLRCLGK | 151 | P85037 | |
| IFSILHYIPFTCRLE | 276 | P25106 | |
| SFDPCFYRDLLLVHR | 331 | Q9Y2A9 | |
| RALHKAPYYFLLDLC | 51 | Q9NS66 | |
| LYPLCHHSFRRAFTK | 411 | Q9Y5N1 | |
| RLLYCIKADPHCLNF | 886 | P13612 | |
| AYPFLKARFNLDHIL | 56 | A6PVL3 | |
| FPFCARLLYKDLTAT | 231 | Q9BU64 | |
| ICDFYSLIRLHFIPR | 41 | Q3SXM5 | |
| RLAKDYTGLFFCHPL | 666 | Q12864 | |
| DFVTLCIIHRYLDFK | 741 | A5D8W1 | |
| IESRFYKHPFTCFAK | 301 | P14778 | |
| LAHFRDRGKFCLTYE | 576 | Q92523 | |
| LHVCLKYGRLFVEAF | 1291 | Q9BXW9 | |
| YDRFLAICKPLHYAT | 141 | Q8NH81 | |
| KFPCHRLVLAAFSPY | 41 | Q3ZCT8 | |
| AFLAFERYIVICKPF | 126 | P03999 | |
| VIDHYFCDLQPLFKL | 171 | Q8NGF8 | |
| RLFHPKLIIAGTSCY | 191 | P34896 | |
| FLVCFAPYHLVLLVK | 251 | Q9UNW8 | |
| TPELFKYFSQHLPRC | 461 | Q8N461 | |
| SFVNPLLYPLCHKRF | 351 | Q9H3N8 | |
| KELFCELSPLEFRLY | 551 | Q9Y4G2 | |
| SHKEFRFIYPVLPFC | 356 | Q92521 | |
| TLLSYFYKCPVRLHL | 141 | Q96EL2 | |
| IYLERFPIFKACFSA | 291 | Q9Y5J1 | |
| ASHPILCRDKIFYLF | 166 | O95219 | |
| SIVCYLSLPHLKFAR | 206 | Q14542 | |
| LYCLKIASFSHPTFL | 106 | Q9NYW6 | |
| LLHFFCLPFIVKHAY | 131 | A0A494BZU4 | |
| EKELLSLFCFFSLPH | 336 | Q969F9 | |
| FEFPYVAHLRFRCPK | 166 | Q9NQV8 | |
| FILFCHNIKAPYIAS | 241 | Q9HCL2 | |
| PAYFRSLLCSKHPAA | 211 | Q1XH10 | |
| LECNPTARIYRKHFL | 81 | P47736 | |
| HPFLCAADFRKIASL | 61 | Q9Y274 | |
| FALCSLLRHFPYAQR | 291 | Q9H173 | |
| AEHFYLKALSLCNSP | 1211 | Q8TE82 | |
| ILLTFFHPFLVYREC | 466 | Q8NBI5 | |
| PFCSKVRAFLDFHAL | 111 | Q9H7Z7 | |
| AHEYCLKFTKLLRFA | 186 | O94864 | |
| LKYEPFLDCALSRFL | 646 | P42338 | |
| YSPLLKLACSHDFTF | 181 | Q8WZ94 | |
| DSFKRLIYPLLCREF | 491 | Q8N5C6 | |
| FLFPLYAKEIHSRVD | 86 | Q13326 | |
| LKFNRERITYCHLPF | 151 | Q9Y2K9 | |
| HKFVLYARCPLLIQY | 706 | Q8IY92 | |
| SCRAHFERYLLSQKP | 391 | O15204 | |
| KKILFYCHFPDLLLT | 131 | Q9H553 | |
| YCHFPDLLLTKRDSF | 136 | Q9H553 | |
| AIYFPVYAHCKLLLA | 496 | O75746 | |
| AKACFLRDIPFSAIY | 486 | Q9UJS0 | |
| FLCDLYVLEHFITPL | 196 | Q7LGC8 | |
| CFLLRKLVLPEYSIH | 61 | Q8TBE1 | |
| VFYCAKVASVRHPLF | 101 | Q9NYW7 | |
| HFRLARCLFELKYVA | 436 | Q8N5D0 | |
| KAFYFLNLCLIHERI | 206 | P17024 | |
| FACHQFYILHRKPFV | 2256 | Q8N2C7 | |
| STLVKCLYLFFDLPH | 151 | Q8IZQ1 | |
| SFLKARLICHIPLYE | 286 | Q9NTN9 | |
| PLHDFYCSRLLDLVF | 1266 | P04275 | |
| LFAECHKVLAPATFY | 2146 | P04275 | |
| FLQYHVLSDSKPLAC | 521 | Q96DM3 | |
| FLFAKHYLFCIAAIL | 196 | A6NEH6 | |
| HKARFSYILPILGIC | 71 | O43353 | |
| FCIHITNYKPALSFI | 151 | Q2MV58 | |
| CDARKGLRFLHFPYL | 371 | Q96K76 | |
| TDPFHLCAAVLAKYL | 151 | P35504 | |
| CHFLLDFLSIYRPLS | 841 | O60290 | |
| ADFVYKHIVPACFLA | 866 | O43592 | |
| DPLLYKCSFRTRLHF | 226 | Q7Z7G8 | |
| LLACILQLHYFHRPF | 691 | Q92508 | |
| ATFHPLKDYCLETIF | 1346 | Q13395 | |
| YAHFLDLSIIRFCKE | 746 | Q5SVZ6 | |
| PEKYFFLIHCEGTRF | 166 | Q9NRZ5 | |
| CSRYIHDLFPSLIKN | 421 | Q70CQ2 | |
| TKLHCFPLLETALFF | 351 | Q96T83 | |
| LAKLQDPFSLYRCHT | 231 | P21912 | |
| VFQHKLPDCSLRLYG | 326 | Q5VYS8 | |
| LCFLYHEPSKLYQIF | 376 | Q8N5T2 | |
| VTCLLFKALKNFPHY | 426 | Q6WRX3 | |
| EHLFCPYFFKNVLEI | 216 | Q9HAW7 | |
| LFVDFPRKLLVTYCS | 511 | Q7Z402 | |
| LYCKALDFFVPALHY | 306 | Q6PHR2 | |
| PSHLFLCNKIRYLDL | 676 | Q8TDW0 |